Project Grant HT94252410680
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$778K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,560,000.00 to the University of Texas Health Science Center at Houston (UTHealth) to develop drug conjugates of modified LGR4/5/6 ligands for cancer treatment. The funding supports UTHealth's advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award period runs from August 1, 2024...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $669,421.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on the long-term impact of deployment exposures on neuropathy of brainstem pathways, associated symptoms, and health measures in veterans with Gulf War Illness. The research will be performed over a two-year period from September 30, 2024 to...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $1,559,880 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant, titled "PEGASUS: PREGNANCY COMPLICATIONS IN AYA CANCER SURVIVORS," will fund research focused on addressing pregnancy-related complications in adolescent and young adult (AYA) cancer survivors. The project aims to investigate innovative approaches to...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,547,864.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on genetically dissecting the neural circuits underlying anorexia nervosa. The research aims to advance scientific understanding and develop new treatment approaches for this condition, which disproportionately impacts military service members...
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $508,815 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This 4-year award, running from September 1, 2023 to August 31, 2027, will support research to transform healthcare for service members and the public through innovative and...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $493,610 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program to conduct a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The grant, awarded on August 1, 2024, will support this research project over a 3-year period, with a final completion date of July 31, 2027. As...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $737,899 to The University of Texas Health Science Center at San Antonio for a 3-year project to develop and evaluate a non-trauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The research aims to advance medical understanding and treatments for these...